Abstract
A Unique Overlap Syndrome Involving Systemic Sclerosis, Systemic Lupus Erythematosus, and ANCA-associated vasculitis
Clinical Department of Rheumatology, Immunology and Internal Medicine, University Hospital in Krakow, Poland
Doctoral School of Medical and Health Sciences, Jagiellonian University Medical College, Krakow, Poland
Department of Hematology, Jagiellonian University Medical College, Krakow, Poland
Department of Rheumatology and Immunology, Jagiellonian University Medical College, Krakow, Poland
Dermatol Rev/Przegl Dermatol 2026, 113, 240–243
Introduction
Overlap syndromes are uncommon autoimmune conditions in which the criteria for at least two connective tissue diseases are simultaneously fulfilled, posing diagnostic and therapeutic challenges.
Case report
A woman was diagnosed with diffuse cutaneous systemic sclerosis at the age of 36 years based on interstitial lung disease, Raynaud’s phenomenon, sclerodactyly, and dysphagia. Three years later, she developed manifestations consistent with systemic lupus erythematosus, including malar rash, arthritis, pericarditis, and nephritis. At the age of 47 years, progression of renal involvement accompanied by markedly elevated titers of myeloperoxidase antineutrophil cytoplasmic antibodies raised suspicion of antineutrophil cytoplasmic antibody-associated vasculitis. The coexistence of systemic sclerosis, systemic lupus erythematosus, and suspected vasculitis created considerable diagnostic difficulties because renal and systemic manifestations could be attributed to more than one of these conditions.
Conclusions
This case illustrates the diagnostic complexity of a rare systemic sclerosis, systemic lupus erythematosus and clinically suspected ANCA-associated vasculitis with a microscopic polyangiitis-like phenotype involving diffuse cutaneous systemic sclerosis, systemic lupus erythematosus, and clinically suspected antineutrophil cytoplasmic antibody-associated vasculitis. Careful assessment of new or progressive organ involvement is essential to avoid delayed diagnosis.
Keywords
connective tissue diseases, interstitial lung disease, lupus nephritis, myeloperoxidase antibodies
Coverage in
Integrated with

